Humphreys Ioan, Thomas Melanie J, Morgan Karen M
College of Human and Health Sciences, Swansea University.
National Clinical Lead for Lymphoedema in Wales, NHS Wales, Cimla Health and Social Care Centre.
Br J Community Nurs. 2017 Dec 2;22(12):578-585. doi: 10.12968/bjcn.2017.22.12.578.
The aim of this economic analysis was to estimate the economic impact of the On the Ground Education Programme (OGEP) within one local University Health Board (UHB) in Wales.
The burden of managing chronic oedema can be considerable to the NHS. Developing innovative solutions to the care and management of patients with chronic oedema has the potential to deliver prudent, cost-effective and high quality care within NHS Wales.
The study was a pilot Evaluation of the OGEP using retrospectively and prospectively collected patient recalled data.
A questionnaire collected health care service use data prior to receiving the OGEP (baseline) and at 3 months follow-up from 97 patients during the period June 2016 and January 2017. In addition, we analysed a patient reported health outcome using the EQ-5D 5L, which was completed by patients at the same two assessment points.
RESULTS/FINDINGS: The total cost of managing chronic oedema in the 97 patients recruited was £563 729 (mean patient cost £5812 SD (£5870) at baseline and £445 098 (including the addition of intervention costs) (mean patient cost £4589 (SD £5465) at 3 months follow-up. Improvements in the EQ-5D 5L score increasing from 0.40 (SD 0.25) at baseline to 0.54 (SD 0.23) at 3 months follow-up.
Our research show health care resource use and costs decreased, while health-related quality of life scores increased.
本经济分析旨在评估威尔士一家地方大学健康委员会(UHB)内的实地教育项目(OGEP)的经济影响。
管理慢性水肿的负担对英国国家医疗服务体系(NHS)而言可能相当大。开发针对慢性水肿患者护理和管理的创新解决方案,有潜力在威尔士NHS内提供审慎、具成本效益且高质量的护理。
本研究是一项对OGEP的试点评估,使用回顾性和前瞻性收集的患者回忆数据。
通过问卷调查收集了97名患者在2016年6月至2017年1月期间接受OGEP之前(基线)以及随访3个月时的医疗服务使用数据。此外,我们使用EQ - 5D 5L分析了患者报告的健康结果,该量表由患者在相同的两个评估点完成。
结果/发现:招募的97名患者中,管理慢性水肿的总成本在基线时为563,729英镑(平均患者成本为5812英镑,标准差为5870英镑),在随访3个月时为445,098英镑(包括干预成本)(平均患者成本为4589英镑,标准差为5465英镑)。EQ - 5D 5L评分从基线时的0.40(标准差0.25)提高到随访3个月时的0.54(标准差0.23)。
我们的研究表明,医疗资源的使用和成本下降,而与健康相关的生活质量评分提高。